Breaking News
Subscribe Now 0
🧐 ProPicks AI October update is out now! See which stocks made the list Pick Stocks with AI
Close

Milestone Pharmaceuticals Inc (MIST)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Milestone Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.500 0.000    0.00%
04/10 - Closed. Currency in USD ( Disclaimer )
After Hours
1.538
+0.038
+2.533%
19:16:37 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 99,324
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.495 - 1.550
Milestone Pharmaceuticals 1.500 0.000 0.00%

NASDAQ:MIST Financials

 
A brief overview of the NASDAQ:MIST financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Milestone Pharmaceuticals Inc over time.

Milestone Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported net loss was USD 9.36 million compared to USD 16.04 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.37 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to USD 0.37 a year ago.For the six months, net loss was USD 19.72 million compared to USD 30.99 million a year ago. Basic loss per share from continuing operations was USD 0.34 compared to USD 0.72 a year ago. Diluted loss per share from continuing operations was USD 0.34 compared to USD 0.72 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MIST Income Statement

Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM -47.63%
 Total Revenue  Net Income
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Revenue 0
Gross Profit 0
Operating Income -9.66 -10.48 -13.8 -15.36
Net Income -9.36 -10.35 -13.61 -15.08

MIST Balance Sheet

Quick Ratio MRQ 18.23
Current Ratio MRQ 19.13
LT Debt to Equity MRQ 161.15%
Total Debt to Equity MRQ 166.53%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Assets 89.23 96 75.23 87.12
Total Liabilities 57.25 56.08 58.46 58.61
Total Equity 31.98 39.92 16.77 28.5

MIST Cash Flow Statement

Cash Flow/Share TTM -0.56
Revenue/Share TTM -
Operating Cash Flow  -132.39%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -6.05 -8.93 -9.8 -12.16
Cash From Investing Activities 9.48 -27.01 13.68 -10.86
Cash From Financing Activities -0.298 32.32 0.001 0.305
Net Change in Cash 3.13 -3.63 3.88 -22.71
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MIST Comments

Write your thoughts about Milestone Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ramiro Millán Fraile
Ramiro Millán Fraile Nov 27, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this going up, or will continue to go down?
Zoran Labus
Zoran Labus Mar 25, 2021 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
EL KAT
EL KAT Oct 23, 2020 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now what,?
Fernando Soto
Fernando Soto Jul 27, 2020 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy
Ahmad Shraim
Ahmad Shraim Jul 24, 2020 11:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strong buy
fx Trade
itr4de Jul 23, 2020 7:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell
Chris Thomas
Chris Thomas Jul 23, 2020 3:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the volatility on this is crazy
Aaron Sandlin
Aaron Sandlin Jul 23, 2020 3:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Smacked me a couple times but I ended up on it
Adam Salas
Adam Salas Jul 23, 2020 3:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
got me during my swipe that's how fast it was going. Had to jump out quickly to recover. think it's ok to get back in where it's at? are there any predictions?
Δημήτρης Ψύρρας
Δημήτρης Ψύρρας Jul 23, 2020 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
booooom babe
Plopseven Schwartz
Plopseven Schwartz Jul 23, 2020 12:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price target: $0.00
fx Trade
itr4de Jul 23, 2020 12:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lmao SELL!
Marco Pereira
Marco Pereira Jul 23, 2020 11:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
afraid of buying now. It's dying off
ADAM ADAMS
ADAM ADAMS Jul 23, 2020 11:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
agree, watching to get back in around $5-$6
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email